Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 abril 2013

JOURNAL OF VASCULAR SURGERY. Management of limb ischemia in acute proximal aortic dissection

Kristofer M. Charlton-Ouw, MD, Kaji Sritharan, MD, Samuel S. Leake, BS, Harleen K. Sandhu, MD, Charles C. Miller III, PhD, Ali Azizzadeh, MD, Hazim J. Safi, MD, Anthony L. Estrera, MD

Background: Management of limb and other malperfusion syndromes is controversial in acute type A aortic dissection. We assessed our hypothesis that urgent proximal aortic repair resolves most cases of limb ischemia without additional peripheral revascularization.

01 abril 2013

JOURNAL OF VASCULAR SURGERY. Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications

Michele Piazza, MD, Paolo Frigatti, MD, Paolo Scrivere, MD, Stefano Bonvini, MD, PhD, Franco Noventa, MD, Joseph J. Ricotta II, MD, MS, Franco Grego, MD, Michele Antonello, MD, PhD

Objective: The goal of this study was to evaluate the role of intraoperative aneurysm sac embolization during endovascular aneurysm repair (EVAR) using a standard dose of coils and fibrin glue in the prevention of type II endoleak (EII).

01 abril 2013

JOURNAL OF VASCULAR SURGERY. Peripheral arterial disease in women

Victoria J. Teodorescu, MD, MBA, Ashley K. Vavra, MD, Melina R. Kibbe, MD

Peripheral arterial disease (PAD) affects a significant portion of the United States population, and much research has been conducted on identifying populations at risk for PAD, evaluating appropriate diagnostic modalities for PAD, studying the effect of risk factor reduction on PAD progression, and determining the best method of treatment for symptomatic PAD. However, most PAD research and clinical trials have focused on whole populations, or populations consisting mostly of men. Little data exist with respect to PAD in women. The goal of this review is to highlight what is known about gender-related differences for PAD.

01 abril 2013

JOURNAL OF VASCULAR SURGERY. Diseases of the thoracic aorta in women

Tam T.T. Huynh, MD, Jean E. Starr, MD, FACS

Women have now equaled or surpassed men in the number of cardiovascular deaths per year in published statistics. In 2006, according to the National Center for Health Statistics and the Center for Disease Control, cardiovascular disease was the cause of death in 428,906 women (35% of all deaths in women) and in 394,840 men (33% of all deaths in men). Of those numbers, it was estimated that 5506 women (0.4% of all deaths in women) and 7732 men (0.6%) died because of aortic aneurysm or dissection. Currently, aortic disease ranks as the 19th leading cause of death with reported increases in incidence. Historically, aortic disease is thought to affect men more frequently than women with a varying reported gender ratio. Gender bias has long been implicated as an important factor, but often overlooked, in the analysis and interpretation of cardiovascular diseases outcome, in part, because of the under-representation of women in clinical trials and studies. In this section, we provide an up-to-date review of the epidemiology and management of common diseases of the thoracic aorta, focusing on the differences and similarities in women and men.

01 abril 2013

JOURNAL OF VASCULAR SURGERY. Abdominal aortic aneurysms in women

Jean E. Starr, MD, FACS, Vivienne Halpern, MD, FACS

Abdominal aortic aneurysms have an incidence that is approximately four to six times higher in men than in women. However, the incidence in women also rises with older age, although starting later in life than in men. There are also sex differences in the risk of rupture and in outcomes after endovascular and open abdominal aortic aneurysm repair. Various explanations have been proposed. Women historically have been under-represented in clinical trials to evaluate the differences between the sexes. We present a review of current recommendations and recent literature to help identify some of these differences.

01 abril 2013

JOURNAL OF VASCULAR SURGERY. Venous disease in women: Epidemiology, manifestations, and treatment

Joann M. Lohr, MD, Ruth L. Bush, MD, MPH

Until the past decade, venous disease was commonly underdiagnosed and undertreated due to lack of interest on the part of providers and to reluctance to undergo procedures on the part of patients. Modern venous interventions, improved diagnostic modalities, and increased awareness through education, training, and screening programs have all raised enthusiasm for venous disease in recent years. This has been crucial to gain control over a disease that affects a significant proportion of the population, with women being affected more than men. This article will discuss epidemiologic studies that highlight some of the gender-related issues and review the risk factors for venous disease. We will also discuss the physiologic venous changes that occur with pregnancy and highlight functional venous disease in women. Finally, we will review the indications for and treatment of superficial venous disease.

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. Results of elective and emergency endovascular repairs of popliteal artery aneurysms

Magdiel Trinidad-Hernandez, MD, Joseph J. Ricotta II, MD, Peter Gloviczki, MD, Manju Kalra, MBBS, Gustavo S. Oderich, MD, Audra A. Duncan, MD, Thomas C. Bower, MD

Objective: Endovascular repair has emerged as a treatment option for popliteal artery aneurysms. Our goal was to analyze outcomes of elective and emergency endovascular popliteal artery aneurysm repair (EVPAR).

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. Evolving treatment of popliteal artery aneurysms

Patrick A. Stone, MD, Priyanka Jagannath, Stephanie N. Thompson, PhD, John E. Campbell, MD, Albeir Y. Mousa, MD, Kimball Knackstedt, DO, Stephen M. Hass, MD, Ali F. AbuRahma, MD

Background: Over the past decade, the treatment of popliteal aneurysms has evolved at our institution from sole operative intervention during the initial part of the study period, to combined surgical and endovascular treatment, and finally to endovascular-centered management in more recent years.

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. Selective coverage of the left subclavian artery without revascularization in patients with bilateral patent vertebrobasilar junctions during thoracic endovascular aortic repair

Minwook Lee, MD, Do Yun Lee, MD, Man-Deuk Kim, MD, Jong Yun Won, MD, Young-Nam Yune, MD, Taek Yeon Lee, MD, Donghoon Choi, MD, Young-Guk Ko, MD

Objective: The primary purpose of the current study was to evaluate the safety and effectiveness of selective coverage of the left subclavian artery (LSCA) without revascularization during thoracic endovascular aortic repair (TEVAR) in patients with bilateral patent vertebrobasilar junctions. The secondary purpose was to assess morphologic change of the vertebral artery (VA) after the procedure.

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. Transrenal E-XL stenting to resolve or prevent type Ia endoleak in the case of severe neck angulation during endovascular abdominal aortic aneurysm repair

Emiliano Chisci, MD, Giorgio Ventoruzzo, MD, Neri Alamanni, PPhys, Guido Bellandi, MD, Stefano Michelagnoli, MD

During endovascular abdominal aortic aneurysm repair, a severely angulated neck can make proximal sealing of endografts challenging, and the occurrence of a type Ia endoleak can complicate the procedure. We describe an original adjunctive procedure involving transrenal placement of a self-expanding nitinol stent (E-XL aortic stent; Jotec GmbH, Hechingen, Germany) to remodel the proximal aortic neck and treat or prevent type Ia endoleaks in the case of severe angulation of the proximal neck.

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. Incidence and treatment results of Endurant endograft occlusion

Laura van Zeggeren, MD, Frederico Bastos Gonçalves, MD, Joost A. van Herwaarden, MD, PhD, Herman J.A. Zandvoort, MD, Debora A.B. Werson, MPA, Jan-Albert Vos, MD, PhD, Frans L. Moll, MD, PhD, Hence J. Verhagen, MD, PhD, Jean-Paul P.M. de Vries, MD, PhD

Objective: The Endurant endograft (Medtronic Inc, Minneapolis, Minn) is a new-generation device specifically developed to perform well in complex abdominal aortic aneurysm anatomy. Previous reports on the 1- and 2-year results of endovascular aneurysm repair (EVAR) with the Endurant endograft showed excellent outcome, including prevention of migration and type I endoleaks, but occurrence and outcome of post-EVAR occlusion have not been determined in a large multicenter patient cohort with midterm follow-up, which is the objective of this study.

01 mayo 2013

JOURNAL OF VASCULAR SURGERY. The impact of hemodynamic status on outcomes of endovascular abdominal aortic aneurysm repair for rupture

Manish Mehta, MD, MPH, Philip S.K. Paty, MD, John Byrne, MCh, FRCSI(Gen), Sean P. Roddy, MD, John B. Taggert, MD, Yaron Sternbach, MD, Kathleen J. Ozsvath, MD, R. Clement Darling III, MD

To date, there are no published reports comparing hemodynamically (Hd)-stable and Hd-unstable patients with ruptured abdominal aortic aneurysms (r-AAAs) undergoing endovascular aneurysm repair (EVAR).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.